Designed and manufactured locally, Renalyx– RxT 21 leverages latest technologies including cloud-based telenephrology platforms to offer safety and quality care to kidney patients, end-stage renal disease patients especially those with cardiovascular, pulmonary and acute kidney injury-related issues, the company said in a statement Wednesday.
On the investment side, the statement said it plans to invest Rs 800 crore in the next four years to build the manufacturing capacity of 5,000 machines by the end of FY26 and an additional capacity of 1500 machines by FY28.
It has manufacturing facilities in Bengaluru and Mysuru in Karnataka and in Mumbai to support its scale-up plans and meet the growing demand, Dr. Shyam Vasudeva Rao, founder of Renalyx said. The company was established in 2012 in Bengaluru.